- Our Work
- Get Involved
Letter from the Directors
Dear Friends and Colleagues,
By traditional academic measures, 2018 was busy year; 114 studies were active, we delivered 53 presentations, and we published 59 papers. The growth is exciting (if sometimes a little painful).
We have remained steadfast in our focus to address the top global health priorities. In fact, the World Health Organization recently named the list of top 10 Threats to Global Health for 2019, and CCGHE’s research, education, and mobile health technology work has addressed all but one of the health challenges named by WHO. Our active work is addressing 5 of the priorities. We are confident that during a period of growth, we have maintained a focus that is well aligned with what the world needs.
2018 saw the end of our long-standing Fogarty HIV and tuberculosis training program in India, which was not funded for another cycle. Over the years we have provided research training and mentorship to more than 150 Indian clinician scientists, with our most recent program including 20 Indian clinicians. We remain committed to building infectious disease research capacity and are actively seeking support to continue this important focus. While our Fogarty-funded work in India ended, we embarked on an exciting new Fogarty training initiative in Uganda in collaboration with Makerere University and the Rakai Health Sciences Program. Twenty-two trainees will be involved in implementation science, geospatial analysis/infectious disease dynamics, and virology/immunology/HIV cure.
We remain grateful to Johns Hopkins University leadership for their support of our work around the world—in India, in Uganda, in Venezuela, in our home city of Baltimore, and points in between. And we are immensely thankful for our funders and supporters—particularly to Raj and Kamla Gupta of the Ujala Foundation of Newtown Square, Pennsylvania, and to David Haas of the Wyncote Foundation. Their sustained commitment to global health is inspiring, and the trust they place in us to improve patient outcomes in resource limited communities around the world is humbling.